Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype

References

• Hitchler MJ, Domann FE. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med 2009; 47:115 - 27; http://dx.doi.org/10.1016/j.freeradbiomed.2009.04.010; PMID: 19362589
   PubMed Web of Science ®Google Scholar
• Teperino R, Schoonjans K, Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell Metab 2010; 12:321 - 7; http://dx.doi.org/10.1016/j.cmet.2010.09.004; PMID: 20889125
   PubMed Web of Science ®Google Scholar
• Burgio G, Onorati MC, Corona DF. Chromatin remodeling regulation by small molecules and metabolites. Biochim Biophys Acta 2010; 1799:671 - 80; http://dx.doi.org/10.1016/j.bbagrm.2010.05.007; PMID: 20493981
   PubMed Web of Science ®Google Scholar
• Rajendran P, Williams DE, Ho E, Dashwood RH. Metabolism as a key to histone deacetylase inhibition. Crit Rev Biochem Mol Biol 2011; 46:181 - 99; http://dx.doi.org/10.3109/10409238.2011.557713; PMID: 21599534
   PubMed Web of Science ®Google Scholar
• Thangaraju M, Gopal E, Martin PM, Ananth S, Smith SB, Prasad PD, et al. SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases. Cancer Res 2006; 66:11560 - 4; http://dx.doi.org/10.1158/0008-5472.CAN-06-1950; PMID: 17178845
   PubMed Web of Science ®Google Scholar
• Ferreira LMR, Hebrant A, Dumont JE. Metabolic reprogramming of the tumor. Oncogene 2012; 31:3999 - 4011; http://dx.doi.org/10.1038/onc.2011.576; PMID: 22231450
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683 - 92; http://dx.doi.org/10.1016/j.cell.2007.01.029; PMID: 17320506
   PubMed Web of Science ®Google Scholar
• Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012; 22:50 - 5; http://dx.doi.org/10.1016/j.gde.2012.02.008; PMID: 22402447
   PubMed Web of Science ®Google Scholar
• Simpson NE, Tryndyak VP, Beland FA, Pogribny IP. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Res Treat 2012; 133:959 - 68; http://dx.doi.org/10.1007/s10549-011-1871-x; PMID: 22101407
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313 - 24; http://dx.doi.org/10.1038/onc.2009.358; PMID: 19881548
   PubMed Web of Science ®Google Scholar
• Erickson JW, Cerione RA. Glutaminase: a hot spot for regulation of cancer cell metabolism?. Oncotarget 2010; 1:734 - 40; PMID: 21234284
   PubMed Web of Science ®Google Scholar
• Daye D, Wellen KE. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol 2012; 23:362 - 9; http://dx.doi.org/10.1016/j.semcdb.2012.02.002; PMID: 22349059
   PubMed Web of Science ®Google Scholar
• Wang J-B, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010; 18:207 - 19; http://dx.doi.org/10.1016/j.ccr.2010.08.009; PMID: 20832749
   PubMed Web of Science ®Google Scholar
• Asiago VM, Alvarado LZ, Shanaiah N, Gowda GA, Owusu-Sarfo K, Ballas RA, et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 2010; 70:8309 - 18; http://dx.doi.org/10.1158/0008-5472.CAN-10-1319; PMID: 20959483
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324:1076 - 80; http://dx.doi.org/10.1126/science.1164097; PMID: 19461003
   PubMed Web of Science ®Google Scholar
• Katt WP, Ramachandran S, Erickson JW, Cerione RA. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. Mol Cancer Ther 2012; 11:1269 - 78; http://dx.doi.org/10.1158/1535-7163.MCT-11-0942; PMID: 22496480
   PubMed Web of Science ®Google Scholar
• Steward MM, Lee J-S, O’Donovan A, Wyatt M, Bernstein BE, Shilatifard A. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 2006; 13:852 - 4; http://dx.doi.org/10.1038/nsmb1131; PMID: 16892064
   PubMed Web of Science ®Google Scholar
• Tate CM, Lee JH, Skalnik DG. CXXC finger protein 1 restricts the Setd1A histone H3K4 methyltransferase complex to euchromatin. FEBS J 2010; 277:210 - 23; http://dx.doi.org/10.1111/j.1742-4658.2009.07475.x; PMID: 19951360
   PubMed Web of Science ®Google Scholar
• Robin P, Fritsch L, Philipot O, Svinarchuk F, Ait-Si-Ali S. Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a. Genome Biol 2007; 8:R270; http://dx.doi.org/10.1186/gb-2007-8-12-r270; PMID: 18096052
   PubMed Web of Science ®Google Scholar
• Vaquero A, Sternglanz R, Reinberg D. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007; 26:5505 - 20; http://dx.doi.org/10.1038/sj.onc.1210617; PMID: 17694090
   PubMed Web of Science ®Google Scholar
• Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 2010; 70:8981 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-10-1666; PMID: 21045145
   PubMed Web of Science ®Google Scholar
• Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330:1340 - 4; http://dx.doi.org/10.1126/science.1193494; PMID: 21127244
   PubMed Web of Science ®Google Scholar
• Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res 2001; 61:4892 - 900; PMID: 11406568
   PubMed Web of Science ®Google Scholar
• Zhang M, Guo R, Zhai Y, Yang D. LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Lett 2003; 195:201 - 10; http://dx.doi.org/10.1016/S0304-3835(03)00148-4; PMID: 12767529
   PubMed Web of Science ®Google Scholar
• Carbone GM, Napoli S, Valentini A, Cavalli F, Watson DK, Catapano CV. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucleic Acids Res 2004; 32:4358 - 67; http://dx.doi.org/10.1093/nar/gkh744; PMID: 15314206
   PubMed Web of Science ®Google Scholar
• Dubská L, Andera L, Sheard MA. HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis. FEBS Lett 2005; 579:4149 - 58; http://dx.doi.org/10.1016/j.febslet.2005.06.047; PMID: 16023111
   PubMed Web of Science ®Google Scholar
• Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 2006; 66:3963 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-06-0743; PMID: 16618711
   PubMed Web of Science ®Google Scholar
• Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, et al. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 2009; 277:133 - 40; http://dx.doi.org/10.1016/j.canlet.2008.11.029; PMID: 19135778
   PubMed Web of Science ®Google Scholar
• Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011; 11:558 - 72; http://dx.doi.org/10.1038/nrc3090; PMID: 21734724
   PubMed Web of Science ®Google Scholar
• Lin Y, Cui H, Xu H, Yue L, Xu H, Jiang L, et al. Jolkinolide B induces apoptosis in MDA-MB-231 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Rep 2012; 27:1976 - 80; PMID: 22426554
   PubMed Web of Science ®Google Scholar
• Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T’Ang A, Fung YK, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995; 14:461 - 72; PMID: 7859736
   PubMed Web of Science ®Google Scholar
• Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444:61 - 6; http://dx.doi.org/10.1038/nature05194; PMID: 17080083
   PubMed Web of Science ®Google Scholar
• Tryndyak VP, Beland FA, Pogribny IP. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 2010; 126:2575 - 83; PMID: 19839049
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pu X, Shi M, Chen L, Qian L, Song Y, et al. c-Jun, a crucial molecule in metastasis of breast cancer and potential target for biotherapy. Oncol Rep 2007; 18:1207 - 12; PMID: 17914574
   PubMed Web of Science ®Google Scholar
• Engelmann D, Pützer BM. The dark side of E2F1: in transit beyond apoptosis. Cancer Res 2012; 72:571 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-11-2575; PMID: 22298593
   PubMed Web of Science ®Google Scholar
• Kwon MJ, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, et al. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis 2010; 31:974 - 83; http://dx.doi.org/10.1093/carcin/bgp336; PMID: 20053926
   PubMed Web of Science ®Google Scholar
• Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012; 13:343 - 57; http://dx.doi.org/10.1038/nrg3173; PMID: 22473383
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693 - 705; http://dx.doi.org/10.1016/j.cell.2007.02.005; PMID: 17320507
   PubMed Web of Science ®Google Scholar
• Sims RJ 3rd, Reinberg D. Histone H3 Lys 4 methylation: caught in a bind?. Genes Dev 2006; 20:2779 - 86; http://dx.doi.org/10.1101/gad.1468206; PMID: 17043307
   PubMed Web of Science ®Google Scholar
• Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012; 13:297 - 311; PMID: 22473470
   PubMed Web of Science ®Google Scholar
• Lüscher-Firzlaff J, Gawlista I, Vervoorts J, Kapelle K, Braunschweig T, Walsemann G, et al. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res 2008; 68:749 - 58; http://dx.doi.org/10.1158/0008-5472.CAN-07-3158; PMID: 18245475
   PubMed Web of Science ®Google Scholar
• Kassis ES, Zhao M, Hong JA, Chen GA, Nguyen DM, Schrump DS. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg 2006; 131:298 - 306; http://dx.doi.org/10.1016/j.jtcvs.2005.05.022; PMID: 16434257
   PubMed Web of Science ®Google Scholar
• Lee J-H, You J, Dobrota E, Skalnik DG. Identification and characterization of a novel human PP1 phosphatase complex. J Biol Chem 2010; 285:24466 - 76; http://dx.doi.org/10.1074/jbc.M110.109801; PMID: 20516061
   PubMed Web of Science ®Google Scholar
• Menssen A, Hydbring P, Kapelle K, Vervoorts J, Diebold J, Lüscher B, et al. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci U S A 2012; 109:E187 - 96; http://dx.doi.org/10.1073/pnas.1105304109; PMID: 22190494
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101 - 8; http://dx.doi.org/10.1038/nprot.2008.73; PMID: 18546601
   PubMed Web of Science ®Google Scholar